Trevena, Inc. (TRVN) Appoints John M. Limongelli As General Counsel
5/15/2014 9:40:57 AM
Trevena, Inc. (NASDAQ: TRVN), a clinical stage pharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced the appointment of John M. Limongelli, Esq., to the newly created position of Senior Vice President, General Counsel & Corporate Secretary, effective immediately.
Help employers find you! Check out all the jobs and post your resume.
comments powered by